Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

283 requests
Make a request to this authority
Opioid medicines: licensed products in England
Response by Medicines and Healthcare products Regulatory Agency to Georgia Richards on .

Awaiting response.

Our Ref: FOI 19/185         Dear Ms Richards,         RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000         Thank you for your enquiry whi...
Hpv vaccine safety and adverse reactions.
Response by Medicines and Healthcare products Regulatory Agency to Hayley on .

Awaiting classification.

Dear Hayley,         Thank you for your email. Please find the response to your FOI request attached.        Kind Regards, Customer and Informatio...
Over-the-counter codeine-containing medicines: licensed products
Response by Medicines and Healthcare products Regulatory Agency to Georgia Richards on .

Successful.

Dear Georgia Richards, Re: Freedom of Information request - Over-the-counter codeine-containing medicines: licensed products our ref: ISE 19-277...
Fluoridated drinking water is used to prevent disease - why does it evade your regulation?
Response by Medicines and Healthcare products Regulatory Agency to Zac Cox on .

Awaiting classification.

Dr R Zac Cox,   Thank you for your email of 23 February and my apologies for the delay in responding.   MHRA has not ignored the basis of your...
GxP Inspection reports for MHRA inspections of Bristol-Myers Squibb company locations
Response by Medicines and Healthcare products Regulatory Agency to Ben Lloyd on .

Awaiting response.

Our Ref: FOI 19/164 Dear Lee, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry attached and below which we recei...
Statistics of people suffering with liver complications which are linked to the combined oral contraceptive pill
Response by Medicines and Healthcare products Regulatory Agency to Sean Carey on .

Successful.

FOI 19/098 Dear Mr Carey, Thank you for your email. Please find attached the response to your FOI request. Kind Regards Customer Services Communi...
Break-marks on UK liothyronine tablets do not comply with PH.Eur. monograph.
Response by Medicines and Healthcare products Regulatory Agency to Thyroid Ninja on .

Partially successful.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Cases of uveitis, iritis and macular oedema following vaccination
Response by Medicines and Healthcare products Regulatory Agency to R Legal on .

Successful.

FOI 18/388 Dear R Legal, Thank you for your email. Please find attached the response to your FOI request. Kind Regards, Customer Services Comm...
Parallel import licences for liothyronine.
Response by Medicines and Healthcare products Regulatory Agency to Thyroid Ninja on .

Partially successful.

FOI 19/071 Dear Enquirer, Thank you for your email of 7 February 2019, where you have asked several questions on the parallel import licencing for l...
Dates of the next 2 Public MHRA Board Meetings?
Response by Medicines and Healthcare products Regulatory Agency to Thyroid Ninja on .

Successful.

  Dear Thyroid Ninja   Thank you for your email and I apologise for the delayed response.    These next two MHRA Board meetings in public will be...
Infected Blood Inquiry Notice
Response by Medicines and Healthcare products Regulatory Agency to JJ Evans on .

Partially successful.

Dear JJ Evans, Our response to FOI 18/575 was sent on 19 November 2018 to the following e-mail address: [email address]. Please find a copy of our r...
GcMAF Effects on Cancer and Prosecution of David Noakes
Response by Medicines and Healthcare products Regulatory Agency to George Robinson on .

Awaiting classification.

Dear Mr Robinson,   Many thanks for your information request dated 19th February 2019 regarding the product Gc Macrophage Activating Factor (GcMAF...
Statistics of people suffering adverse from Rigevidon
Response by Medicines and Healthcare products Regulatory Agency to Sophie Long on .

Successful.

FOI 18/582   Dear Ms Long,   Thank you for your email.   Please find attached the response to your FOI request.   Kind Regards    ...
Importation of Unlicensed Medicines
Response by Medicines and Healthcare products Regulatory Agency to James Kelly on .

Partially successful.

Dear Mr Kelly,   Thank you for your email.   Please find attached response.   Kind Regards   Customer Services Communications division...
MHRA Yellow Card complaints regarding Ephdrine
Response by Medicines and Healthcare products Regulatory Agency to Lee Johnson on .

Successful.

FOI 19/013   Dear Mr Johnson,   Thank you for your email.   Please find attached the response to your FOI request.   Kind Regards  ...
Haemotherapy
Response by Medicines and Healthcare products Regulatory Agency to Phil Collyer on .

Awaiting classification.

Dear Mr Collyer,   Many thanks for your information request 19th January 2019 dated where you asked what forms of haemotherapy are legally allowed...
Liothyronine v Levothyroxine
Response by Medicines and Healthcare products Regulatory Agency to Allyson Bissett on .

Successful.

Dear Mrs Bissett, Please find attached, the final response to the above-referenced FOI request. Kind regards, FOI Licensing Team MHRA MHRA 10 South...
Request for a structured dataset on granted medicine licenses
Response by Medicines and Healthcare products Regulatory Agency to Brian Mac Kenna on .

Long overdue.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Under FOI Please supply information on Thybon Henning 20mcg liothyronine, under Sanofi-Aventis
Response by Medicines and Healthcare products Regulatory Agency to U Power on .

Partially successful.

Dear Mrs U J Power,   Thank you for your email.   This is an unlicensed medicine, commonly imported to meet the special needs of individual pa...
Yellow Card Scheme/Liothyronine
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Partially successful.

Dear Ms Sanday,   Thank you for your email dated 04 January 2019, where you requested information regarding liothyronine. Please find our response...
MHRA updates of clinical trial statuses on EudraCT
Response by Medicines and Healthcare products Regulatory Agency to Till Bruckner on .

Successful.

Dear Dr Bruckner   Thank you for your email of 8 January 2019 requesting information on MHRA updates of clinical trial statuses on EudraCT.  ...
SPCs and PILs for discontinued products in the last eight years
Response by Medicines and Healthcare products Regulatory Agency to Vijay Singh on .

Awaiting classification.

FOI 19/107 Dear Vijay, Thank you for your email of 12 December where you have asked "I would be grateful if you could provide an excel sheet of medi...
MHRA regulation of medical products containing Ephedrine
Response by Medicines and Healthcare products Regulatory Agency to Lee Johnson on .

Successful.

FOI 18/648 Dear Lee Johnson, Thank you for your email. Please find attached the response to your FOI request. Kind Regards Customer Services Comm...
Numbers of Agency Lawyers 3 Sep 2018 and Cost of agency legal workers 2016/2017
Response by Medicines and Healthcare products Regulatory Agency to Ted Jones on .

Partially successful.

FOI 18/600 Dear Ted Jones, Thank you for your email of 7 November where you have asked 1 - How many lawyers were working on a temporary (agency) ba...
Companies who won tenders for fridges in the event of a no deal Brexit
Response by Medicines and Healthcare products Regulatory Agency to Lee Davies on .

Information not held.

Dear Lee Davies, Thank you for your email of 18 December where you have asked “Under the Freedom of Information Act I would like to know which compan...

Only requests made using WhatDoTheyKnow are shown. ?